EUVIMEDEUVIMED entdecken
Crossref

Overexpressed Poldip2 Incurs Retinal Fibrosis via the TGF-β1/SMAD3 Signaling Pathway in Diabetic Retinopathy

Zhiyu Ji, Siyu Lin, Siyu Gui, Jie Gao, Fan Cao, Yiming Guan, Qinyu Ni, Keyang Chen, Liming Tao, Jiang Zhengxuan iD

Diabetes · 2024

DOI: 10.2337/db23-1036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Zhiyu Ji und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetic Retinopathy, Fibrosis, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Funds for Distinguished Young Scholar of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinal fibrosis is one of the major features of diabetic retinopathy (DR). Our recent research has shown that Poldip2 can affect early DR through oxidative stress, but whether Poldip2 would regulate retinal fibrosis during DR development is still enigmatic. Here, diabetic Sprague-Dawley (SD) rats were induced with streptozotocin (STZ) and treated with adeno-associated virus serotype 9–polymerase-δ interacting protein 2 (Poldip2) shRNA, while human adult retinal pigment epithelial (ARPE-19) cells were treated with high glucose or Poldip2 siRNA. We identified that in STZ-induced DR rats and ARPE-19 cells treated with high glucose, the expression of Poldip2, transforming growth factor-β1 (TGF-β1), phosphorylated-SMAD3/SMAD3, MMP9, COL-1, FN, and CTGF increased while the expression of cadherin decreased. However, deleting Poldip2 inhibited the TGF-β1/SMAD3 signaling pathway and attenuated the above protein expression in vivo and in vitro. Mechanistically, we found that Poldip2 promotes the activation of SMAD3, facilitates its nuclear translocation through interacting with it, and significantly enhances the expression of fibrosis makers. Collectively, Poldip2 was identified is a novel regulator of DR fibrosis and is expected to become a therapeutic target for PDR. Article Highlights

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetic RetinopathyFibrosisSignal TransductionAnimalsHumansMaleRatsCell LineNuclear ProteinsRats, Sprague-DawleyRetinaRetinal Pigment EpitheliumSmad3 ProteinTransforming Growth Factor beta1

Substanzen

Nuclear ProteinsSmad3 ProteinSmad3 protein, ratTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Department of Ophthalmology, The Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
  • Department of Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, Anhui, China.

ORCID-Profile: Jiang Zhengxuan

Förderung

  • National Natural Science Foundation of China
  • Natural Science Funds for Distinguished Young Scholar of Anhui Province

Zitieren

APA

Ji, Z., Lin, S., Gui, S., Gao, J., Cao, F., Guan, Y., Ni, Q., Chen, K., Tao, L., & Zhengxuan, J. (2024). Overexpressed Poldip2 Incurs Retinal Fibrosis via the TGF-β1/SMAD3 Signaling Pathway in Diabetic Retinopathy. Diabetes. https://doi.org/10.2337/db23-1036

Vancouver

Ji Z, Lin S, Gui S, Gao J, Cao F, Guan Y, et al. Overexpressed Poldip2 Incurs Retinal Fibrosis via the TGF-β1/SMAD3 Signaling Pathway in Diabetic Retinopathy. Diabetes. 2024. doi:10.2337/db23-1036

BibTeX
@article{Ji2024,
  author = {Ji, Zhiyu and Lin, Siyu and Gui, Siyu and Gao, Jie and Cao, Fan and Guan, Yiming and Ni, Qinyu and Chen, Keyang and Tao, Liming and Zhengxuan, Jiang},
  title = {Overexpressed Poldip2 Incurs Retinal Fibrosis via the TGF-β1/SMAD3 Signaling Pathway in Diabetic Retinopathy},
  journal = {Diabetes},
  year = {2024},
  doi = {10.2337/db23-1036}
}
Kostenlos starten →